Hypertensive disorders of pregnancy, including preeclampsia, are a leading cause of maternal and infant deaths in the United States. Prompt recognition, management, and treatment of severe hypertension and preeclampsia reduces morbidity and mortality. The MedStar Health Clinical Practice Guideline for Treatment of Women with Hypertensive Disorders in Pregnancy and Clinical Practice Guideline for Magnesium Sulfate for Pre-Eclampsia and Eclampsia provide evidence-based guidance on recognition, treatment, and management of these conditions for providers, midwives, and nursing staff.

• Faculty: Tamika Auguste
• ID: Pr-034910

This course/content offers 1.00 Continuing Professional Education credits. To claim the credits, the course must be completed prior to 10/27/2025. Once your evaluation is complete, under Main Menu in SiTEL click on the CloudCME link and click on My CE/ Transcript to find the credits the next business day. This module provides role specific education to fulfill the Joint Commission requirement for Standard PC.06.01.01: Reduce the likelihood of harm related to maternal hemorrhage, EP 2 and EP4.

• Faculty: Cynthia Heer
• ID: Pr-034137

This course/content offers 1.00 Continuing Professional Education credits. To claim the credits, the course must be completed prior to 10/27/2025. Once your evaluation is complete, under Main Menu in SiTEL click on the CloudCME link and click on My CE/ Transcript to find the credits the next business day. This module provides role specific education to fulfill the Joint Commission requirement for Standard PC.06.01.01: Reduce the likelihood of harm related to maternal hemorrhage, EP 2 and EP4.

• Faculty: Cynthia Heer
• ID: Qu-034136